Showing 101 - 120 results of 349 for search '"pharmacotherapy"', query time: 0.06s Refine Results
  1. 101

    Patients' perceived needs for medical services for non-specific low back pain: A systematic scoping review. by Louisa Chou, Tom A Ranger, Waruna Peiris, Flavia M Cicuttini, Donna M Urquhart, Kaye Sullivan, Maheeka Seneviwickrama, Andrew M Briggs, Anita E Wluka

    Published 2018-01-01
    “…However, there was dissatisfaction with the cursory and superficial approach of care. (2) Patients had concerns about pharmacotherapy, with few studies reporting on patients' preferences for medications. (3) Of the few studies which examined the patients' perceived need of invasive therapies, these found that patients avoided injections and surgeries (4) Patients desired spinal imaging for diagnostic purposes and legitimation of symptoms.…”
    Get full text
    Article
  2. 102
  3. 103

    The child and adolescent patient’s profiles and usefulness of instant collaborative video consultations of tele-psychiatrists with primary care doctors by Rajendra K Madegowda, P Lakshmi Nirisha, Gajanan Ganapati Sabhahit, Narayana Manjunatha, Channavaeerachari Naveen Kumar, Suresh Bada Math

    Published 2024-12-01
    “…Pharmacotherapy was initiated for five patients (12.2%), while 23 patients (56.1%) received counseling, and 13 patients (31.7%) received both treatments. …”
    Get full text
    Article
  4. 104

    Overreliance on Bronchodilators as a Risk Factor for Life-Threatening Asthma by Pierre Ernst, Brenda Hemmelgarn, Donald W Cockcroft, Samy Suissa

    Published 1995-01-01
    “…OBJECTIVE: To assess the potential impact on the risk of life-threatening asthma of current recommendations in pharmacotherapy, which emphasize the early use of steroids and the avoidance of beta-agonist overuse.…”
    Get full text
    Article
  5. 105

    Conservative treatment for cataract: state-of-the-art by S.Yu. Petrov, I.V. Kozlova, R.P. Poleva

    Published 2019-11-01
    “…Despite high occurrence and scientific interest, cataract pathogensis is still an enigma. Pharmacotherapy to inhibit cataractogenesis is a promising but unexplored treatment modality. …”
    Get full text
    Article
  6. 106
  7. 107
  8. 108

    Sarcopenia in IBD patients and the role of nutritional and physical activity interventions in its management – a systematic review by Michalina Jurkiewicz, Karolina Siembab, Julia Białeta, Katarzyna Rowińska, Agnieszka Napieralska, Wiktor Garbarczyk, Albert Kapla, Alicja Černohorská, Daria Bednarczyk, Wiktoria Pysiewicz

    Published 2025-02-01
    “…There is increased probability of therapy failure such as change of pharmacotherapy, hospitalization or surgical intervention, in individuals with sarcopenia. …”
    Get full text
    Article
  9. 109
  10. 110

    Histoplasma capsulatum Infection in an Allogeneic Hematopoietic Stem Cell Transplant Patient Receiving Voriconazole Prophylaxis by Vaibhav Agrawal, Bryan J. Brinda, Sherif S. Farag

    Published 2020-01-01
    “…The patient experienced significant clinical improvement after initiation of itraconazole pharmacotherapy. We recommend a lower threshold for evaluation for histoplasmosis in allogeneic hematopoietic stem cell transplant recipients who live in endemic regions, regardless of their antifungal prophylactic regimen.…”
    Get full text
    Article
  11. 111

    Comparison of effectiveness in smoking cessation using nicotine replacement therapy and electronic cigarettes by Adrianna Kopaczyńska, Katarzyna Szafrańska, Szymon Niemirka, Aleksandra Janiak, Kinga Dominiczak, Łukasz Grądalski, Filip Dębicki

    Published 2025-02-01
    “…Personalized dosing and combined pharmacotherapy with behavioral support are recommended for optimal outcomes. …”
    Get full text
    Article
  12. 112

    Sphincter of Oddi Function and Dysfunction by James Toouli, Alexander Craig

    Published 2000-01-01
    “…Other forms of SO dysfunction may benefit from pharmacotherapy.…”
    Get full text
    Article
  13. 113

    ELDERLY PATIENT WITH CHRONIC HEART FAILURE IN THE GENERAL PRACTICE by V.V. Zhdan, O.Ye. Kitura, Ye.M. Kitura, M.Yu. Babanina, V.G. Volchenko, M.V. Tkachenko

    Published 2017-03-01
    “…The paper elucidates the peculiarities of heart failure course in elderly patients, as well as issues of pharmacotherapy, chronic heart failure. Features of the pathogenetic therapy of ß-blockers and ACE inhibitors, as well as diuretics and cardiac glycosides have been considered.…”
    Get full text
    Article
  14. 114

    Protein restriction in CKD: an outdated strategy in the modern era by Abdullah Bawazir, Joel M Topf, Swapnil Hiremath

    Published 2025-02-01
    “…This review discusses the rational for protein restriction in CKD, critiques the existing evidence, and advocates for personalized care that focuses on nutritional adequacy and effective pharmacotherapy. Important advances in CKD treatment, including ACE inhibitors, SGLT2 inhibitors, and GLP-1 receptor agonists, are discussed to propose a comprehensive strategy that optimizes patient outcomes.…”
    Get full text
    Article
  15. 115

    Drug Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Fibrosis by D. V. Garbuzenko

    Published 2022-01-01
    “…An overview of current pharmacotherapy for non-alcoholic steatohepatitis (NASH)-associated liver fibrosis.Key points. …”
    Get full text
    Article
  16. 116

    Diagnosis and Management of Interstitial Lung Disease in Patients with Connective Tissue Diseases by Matthew Koslow, Mehrnaz Maleki-Fischbach, Rebecca C. Keith

    Published 2021-01-01
    “…Close monitoring of patients with CTD-ILD is important to enable early detection of disease progression and inform decisions regarding the initiation or escalation of pharmacotherapy. In the absence of guidelines regarding how CTD-ILDs should be treated, clinicians face difficult decisions on when to use immunosuppressant and anti-fibrotic therapies. …”
    Get full text
    Article
  17. 117

    Differential Expression Profiles of mRNA and Noncoding RNA and Analysis of Competitive Endogenous RNA Regulatory Networks in Nonalcoholic Steatohepatitis by Mengjia Gao, Jingxin Xin, Xiaoling Li, Ling Gao, Shanshan Shao, Meng Zhao

    Published 2022-01-01
    “…Nonalcoholic steatohepatitis (NASH) is a liver disease caused by multiple factors, and there is no approved pharmacotherapy. The pathogenesis of NASH remains underexplored. …”
    Get full text
    Article
  18. 118

    Evaluating accuracy and reproducibility of large language model performance on critical care assessments in pharmacy education by Huibo Yang, Mengxuan Hu, Amoreena Most, W. Anthony Hawkins, Brian Murray, Susan E. Smith, Sheng Li, Andrea Sikora

    Published 2025-01-01
    “…The purpose of this evaluation was to test various LLMs performance optimization strategies and performance on critical care pharmacotherapy questions used in the assessment of Doctor of Pharmacy students.MethodsIn a comparative analysis using 219 multiple-choice pharmacotherapy questions, five LLMs (GPT-3.5, GPT-4, Claude 2, Llama2-7b and 2-13b) were evaluated. …”
    Get full text
    Article
  19. 119

    Retrospective cross-sectional study on bronchiectasis in adult Aboriginal Australians: disease characteristics and comparison with ethnically diverse global bronchiectasis registry... by Timothy Howarth, Subash Heraganahally, Claire Gibbs, Lata Jayaram, Asanga Abeyaratne, Shiidheshwar J Ravichandran, Davaadorj Erdenebayar, Winnie Chen, Hubertus Jersmann

    Published 2025-01-01
    “…Chest CT demonstrated multilobar and lower lobes involvement in 73% and inhaled pharmacotherapy use was recorded in up to 62% and long-term antibiotics in 5%.Conclusion The overall bronchiectasis disease burden is higher in Aboriginal Australian adults in comparison with global ethnically diverse non-Indigenous populations. …”
    Get full text
    Article
  20. 120